Log in to save to my catalogue

Internalisation of RGD-Engineered Extracellular Vesicles by Glioblastoma Cells

Internalisation of RGD-Engineered Extracellular Vesicles by Glioblastoma Cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_da17629574e34d2baf4761651c8e2ee3

Internalisation of RGD-Engineered Extracellular Vesicles by Glioblastoma Cells

About this item

Full title

Internalisation of RGD-Engineered Extracellular Vesicles by Glioblastoma Cells

Publisher

Basel: MDPI AG

Journal title

Biology (Basel, Switzerland), 2022-10, Vol.11 (10), p.1483

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Glioblastoma multiforme (GBM) is the most aggressive CNS tumour with no efficient treatment, partly due to the retention of anticancer drugs by the blood–brain barrier (BBB) and their insufficient concentration in tumour cells. Extracellular vesicles (EVs) are attractive drug carriers because of their biocompatibility and ability to cross the BBB....

Alternative Titles

Full title

Internalisation of RGD-Engineered Extracellular Vesicles by Glioblastoma Cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_da17629574e34d2baf4761651c8e2ee3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_da17629574e34d2baf4761651c8e2ee3

Other Identifiers

ISSN

2079-7737

E-ISSN

2079-7737

DOI

10.3390/biology11101483

How to access this item